Related Experiment Video
Updated: Feb 15, 2026

Studying the Integration of Adult-born Neurons
Published on: March 25, 2011
Are pre-terms born timely and right immunized? Results of an Italian cohort study
Nicola Laforgia1, Antonio Di Mauro1, Francesco Paolo Bianchi1
1a Department of Biomedical Science and Human Oncology , "Aldo Moro" University of Bari , Bari , Italy.
Insights
Vaccination coverage in preterm infants at 24 months shows high rates for initial doses but significant delays for subsequent vaccinations. This highlights a critical need for improved vaccination strategies for premature babies.
Area of Science:
- Pediatrics
- Neonatology
- Public Health
Background:
- Preterm infants are a vulnerable population requiring timely immunizations.
- Vaccination schedules are crucial for preventing infectious diseases in infants.
- Understanding vaccination coverage in preterm infants is essential for public health initiatives.
Purpose of the Study:
- To evaluate vaccination coverage at 24 months in preterm infants discharged from a Neonatal Intensive Care Unit (NICU).
- To identify potential delays in vaccination schedules for this specific cohort.
- To assess the need for improved vaccination strategies in preterm infants.
Main Methods:
- Retrospective analysis of 159 preterm infants discharged from NICU in 2013.
- Vaccination status at 24 months chronological age obtained from the Apulian Regional Vaccination Register (GIAVA).
- Data collected on hexavalent, pneumococcal conjugate, MMR, Men C, and Varicella vaccines.
Main Results:
- High initial coverage for hexavalent (98.1%) and pneumococcal conjugate (98.7%) vaccines.
- Decreased coverage for subsequent doses (e.g., 87.3% for 3rd hexavalent dose).
- Vaccinations were often delayed, with delays increasing for lower gestational age, birth weight, and longer hospitalization.
Conclusions:
- Preterm infants face a high risk of delayed vaccinations.
- Current vaccination strategies require enhancement for this high-risk group.
- Neonatologists should play a key role in parental counseling and scheduling vaccinations post-NICU discharge.
Abstract:
The aim of this study is to evaluate the vaccination coverage at 24 months of chronological age in a sample of preterm infants discharged by the Neonatal Intensive Care Unit (NICU) of the Bari Policlinico University General Hospital in Italy. The list of infants preterm born discharged during 2013 by the NICU was obtained by hospital database. Vaccination status of each subject at 24 months of chronological age was acquired by the Apulian Regional Vaccination Register (GIAVA). 159 preterm borns were enrolled in this study. 98.1% received the 1st dose of hexavalent vaccine and 98.7% the 1st dose of pneumococcal conjugate vaccine. The 8.8% of hexavalent vaccinations were performed during hospitalization. The percentage of immunized subjects decreased to 91.2% and 87.3% for the 2nd and 3rd dose of hexavalent vaccine and to 90.6% and 86.1% for the 2nd and 3rd dose of pneumococcal conjugate vaccine. Coverage for MMR, MEN C and Varicella vaccines were, respectively 76.4%, 86.0% and 80.9%. Pre-terms received the vaccinations later than the age recommended by public health guidelines. Age at the immunization, for all vaccines, seems to increase for lower gestational age and birth weight and for higher length of hospitalization. This study shows a high risk of vaccine delay among pre-terms born. There is a strong need to improve specific vaccination strategies for this group. Neonatologists might play a key role in informing parents about the vaccination schedule at the moment of NICU discharge and during follow-up, also preparing correct time schedule.
Related Concept Videos
The Born-Haber Cycle
Long-term Depression
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
What is the Immune System?
Pre-mRNA Processing: Modification of pre-mRNA Ends
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...

